CTRI/2009/091/000116招募中3 期
evamisole treatment for children with steroid sensitive nephrotic syndrome: A multicenter, double blind, placebo controlled randomized trial
Emma Childrens Hospital AMC0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Frequently relapsing steroid sensitive nephrotic syndrome with or without steroid dependence
- •Age <18 years
- •Written informed consent
排除标准
- •Previous treatment with levamisole, cyclosporine or mycophenolate mofetil
研究者
相似试验
进行中（未招募）
不适用
evamisole treatment for children with steroid sensitive nephrotic syndrome. A multi-centre, double-blind, placebo-controlled, randomised trial. - Levamisol TrialEUCTR2005-005745-18-BEEmma Children's Hospital-AMC100
已完成
不适用
evamisole treatment for children with steroid sensitive nephrotic syndromeephrotic syndromeUrological and Genital DiseasesNephrotic syndromeISRCTN23853712Academic Medical Centre (AMC) (Netherlands)100
招募中
不适用
evamisole treatment for children with steroid sensitive nephrotic syndrome.steroid sensitive idiopathic nephrotic syndrome(steroid gevoelig idiopathisch nefrotisch syndroom), relapse (recidief), levamisole, steroid side effects (steroid bijwerkingen),NL-OMON26305Academic Medical Center of AmsterdamMeibergdreef 9, 1105 AZ Amsterdam Z-OThe Netherlands100
已完成
不适用
evamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitaemiaSevere falciparum malaria with high parasitaemiaInfections and InfestationsMalariaISRCTN27232551niversity of Oxford (United Kingdom)60
进行中（未招募）
不适用
Rationale for therapy with low dose steroids combined with long-acting beta2-agonists in patients with allergic asthma: redirecting innate immune responses by long-term treatment with high doses of inhaled steroidsAsthmaEUCTR2007-000097-23-NLGlaxoSmithKline